Allied Corp. Files Full Psilocybin Patent For Psilonex To Treat Central Nervous System Disorders
Allied Corp. (OTCQB:ALID) has successfully filed for a full patent regarding “Dosing regimes of pharmaceutical and nutraceutical mushroom and cannabis compositions and their use to treat CNS disorders and improve mental health."
Benzinga ·